|
| |
AnalytiCon
Discovery To Identify New Natural Compounds For Johnson & Johnson
Pharmaceutical Research & Development
Potsdam, Germany (July 12, 2005)
- AnalytiCon Discovery GmbH (AnalytiCon), a specialist in all aspects
of natural product drug discovery, announced it has signed an agreement
that will provide Johnson & Johnson Pharmaceutical Research & Development,
Division of Janssen Pharmaceutica N.V. (J&JPRD), with full access to the
unique chemical diversity contained within AnalytiCon's extensive natural
products biological collection. Financial terms of the agreement were not
disclosed.
According to the agreement, AnalytiCon will apply its proprietary
MEGAbolite® technology to isolate and characterize small molecule
compounds from a variety of biosources to find novel and pharmaceutically
active compounds on behalf of J&JPRD. AnalytiCon will profile both its own
extensive proprietary biological collections and biomaterials provided by
Tibotec Pharmaceuticals Ltd. (Tibotec) that are described in ethno-botany
for active compounds. In addition, AnalytiCon will carry out all tasks
beginning with the acquisition of plant and microbial material, and the
isolation and fractionation of the contained natural product compounds up
to their analytical characterization. AnalytiCon expects to deliver more
than 500 highly purified compounds with fully elucidated structures to J&JPRD
and Tibotec for drug discovery screening activities. AnalytiCon also
expects to establish the resupply protocol in order to guarantee compound
supply for J&JPRD's follow-up discovery work on an as-needed basis.
"We have had a long business relationship with J&JRPD and we are excited
to continue this relationship," said Dr. Lutz Müller-Kuhrt, CEO of
AnalytiCon Discovery GmbH. "We expect to supply a number of novel
compounds and we look forward to working with J&JPRD within their
discovery process."
The internationally operating AnalytiCon Discovery GmbH is a worldwide
market-leader in the field of structurally fully elucidated natural
product libraries. On the basis of its ready-to-screen technology in the
field of natural products (MEGAbolite®) and natural product analogues (NatDiverseTM)
the company enjoys an exceptional market positioning. AnalytiCon has
direct access to roughly a quarter of all known natural compounds
worldwide, i.e. in their pure and structurally fully elucidated form. The
company is able to offer its clients a complete Supply-Chain-Management
from the initial biomaterial to the final lead compound.
About AnalytiCon
AnalytiCon a brand and at the same time successful company, is world's
first address for all needs in connection with natural product drug
discovery. From prospecting for biosources, via fermentation, extraction
and isolation to high throughput structure elucidation, the company
provides a vast portfolio of first class services. Beyond that, AnalytiCon
produces pure natural compound collections and libraries of synthetic,
natural product based molecules carrying relevant bio-active structure
elements. The natural product drug discovery platform is complemented by a
portfolio of medicinal chemistry services. For further information see
www.ac-discovery.com
.
Contact:
AnalytiCon Discovery GmbH
Matthias Hess, Head of Marketing & Sales
Email m.hess@ac-discovery.com
Phone +49 331 2300 300
© BIOCOMMUNICATIONS.net GmbH, Brunnenstr. 128, D-13355 Berlin, Germany
| |
|
